High materiality7/10
Nurix Therapeutics price target raised to $36 from $34 at H.C. Wainwright
Why it may matterVerify against the original reporting
Upside potential indicated by the target raise.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
NRIX target increased to $36; current price about $24.95; implies meaningful upside per the recent target update.
- Target raised to $36 vs $24.95 current; upside potential.
Key facts
- 01
Target: $36
- 02
Posted price: $24.95
- 03
Analyst firm: H.C. Wainwright
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.